Inventor · disambiguated record
Naoise Gaffney
Also filed as: GAFFNEY NAOISE
0 granted patents·22 pending applications·0 citations·filing 2023–2023
Files withGH RES IRELAND LIMITED22
Top patents by PatentIndex Score
22 records- 0176US2024108602A1Treatment of mental disordersGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 0276US2024108601A1Treatment of mental disordersGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 0376US2024115549A1Treatment of mental disordersGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 0476US2024115550A1Treatment of mental disordersGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 0574US2025213528A15-methoxy-n,n-dimethyltryptamine for the treatment of anxietyGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 0674US2025235427A15-methoxy-n,n-dimethyltryptamine for the treatment of social/emotional withdrawal or detachmentGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 0774US2025241895A15-meo-dmt for use in the treatment of sleep disturbanceGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 0874US2025205256A15-meo-dmt for use in the treatment of negative thinkingGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 0974US2025170099A1Treatment of postnatal depressionGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1074US2025213531A15-meo-dtm for the treatment of bipolar disorderGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1174US2025241891A1Treatment of anxietyGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1274US2025241892A15-methoxy-n,n-dimethyltryptamine for the treatment of psychomotor retardationGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1374US2025241893A1Treatment of cognitive dysfunctionGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1474US2025213529A15-methoxy-n.n-dimethyltryptamine for the treatment of psychomotor retardationGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1574US2025205199A15-methoxy-n,n-dimethyltryptamine for the treatment of social/emotional withdrawal or detachmentGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1674US2025213533A15-meo-dmt for use in the treatment of sleep disturbanceGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1774US2025213532A15-methoxy-n,n-dimethyltryptamine for the treatment of bipolar disorderGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1874US2025213530A15-meo-dmt for use in the treatment of negative thinkingGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1974US2025213534A15-methoxy-n,n-dimethyltryptamine for the treatment of cognitive dysfunctionGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 2050US2025205200A15-methoxy-n,n-dimethyltryptamine for the treatment of postpartum depressionGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 2150US2025241894A1Treatment of mental disordersGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 2250US2025221963A15-meo-dmt for use in the treatment of postpartum depressionGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Naoise Gaffney files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →